Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Liabilities ₹14,925 Cr₹13,309 Cr₹17,566 Cr₹15,397 Cr₹14,069 Cr

What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹14,925 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹14,925 Cr
Mar2024₹13,309 Cr
Mar2023₹17,566 Cr
Mar2022₹15,397 Cr
Mar2021₹14,069 Cr

How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2025 ₹14,925 Cr
12.15
Mar2024 ₹13,309 Cr
-24.23
Mar2023 ₹17,566 Cr
14.08
Mar2022 ₹15,397 Cr
9.44
Mar2021 ₹14,069 Cr -

Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,362.0 Cr 1.1% 1.7% 26.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.1%

1.7%

26.8%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses